Taken together, our findings provide functional evidence for the presence of ␤ ␤3-like adrenoceptors in the eel Anguilla anguilla heart identifying, for the first time in a working fish heart, the ␤ ␤3-AR-dependent negative inotropy discovered in mammals.
Introduction
The sympathetic neurohumoral system is an essential regulator of cardiovascular homeostasis, metabolism and immune system in vertebrates. Its principal end products are nor-adrenaline and adrenaline, called catecholamines, which exert a variety of actions at their target cells, through interaction with the adrenoceptor system (Xiao et al., 1999; Brodde et al., 2006) .
In 1967, Lands et al. classified the ␤-adrenergic receptors (␤-ARs) into ␤1 and ␤2 based on the rank order, in different tissues, of the potency of the two catecholamines, adrenaline and nor-adrenaline (Lands et al., 1967) . Both ␤-ARs have been identified in the mammalian heart where they are responsible for most of the adrenergic-mediated effects on cardiac performance, i.e. positive inotropic, chronotropic and lusitropic responses (Brodde, 1991) . To a large extent these effects result from an elevation of intracellular cAMP after adenylyl cyclase stimulation through Gs proteins (Ishikawa and Homcy, 1997) .
In various mammalian tissues, including the heart, recent molecular and pharmacological studies have identified, besides the classic ␤1-and ␤2-ARs, a new receptor, called ␤3-AR (Gauthier et al., 1996; Gauthier et al., 1998; Varghese et al., 2000; Tavernier et al., 2003; Boivin et al., 2006) . ␤3-AR, as well as ␤1-and ␤2-ARs, belongs to the G-protein coupled receptors characterized by seven transmembrane domains of 22-28 amino acids showing three intracellular and three extracellular loops. It shares 51% and 46% identity with ␤1-and ␤2-AR amino acid sequences, respectively, and is activated by selective pharmacological agonists (BRL 37344 , SR 58611 , CGP 12177 ), which have little effect on ␤1-and ␤2-ARs (Skeberdis, 2004) . Using synthetic ␤3-AR agonists, several studies have shown that ␤3-AR activation induces Neuroendocrine regulation of cardiac function involves a population of three types of ␤ ␤-adrenoceptors (ARs). In various mammalian species, ␤ ␤1-and ␤ ␤2-AR stimulation produces an increase in contractility; whereas ␤ ␤3-AR activation mediates negative inotropic effects. At the moment, nothing is known about the physiological role of ␤ ␤3-AR in fish.
Using an isolated working heart preparation, we show that a ␤ ␤3-AR selective agonist BRL 37344 (0.1-100·nmol·l -1 ) elicits a dose-dependent negative inotropism in the freshwater eel Anguilla anguilla. This effect was insensitive to the ␤ ␤1/␤ ␤2-AR inhibitor nadolol (10· mol·l ) induced, in 30% of the preparations, a negative inotropic effect that was abrogated by pre-treatment with SR 59230, pointing to a ␤ ␤3-mediated pathway. The BRL 37344 -induced negative inotropic effect was abolished by exposure to a G i/o proteins inhibitor pertussis toxin (PTx; 0.01·nmol·l -1 ), suggesting a G i/o -dependent mechanism. Using L-N5(limino-ethyl)ornithine (L-NIO; 10· mol·l Role of ␤3-AR in the eel heart metabolic and functional processes in many tissues (Bianchetti and Manara, 1990; McLaughlin and MacDonald, 1990; Norman and Leathard, 1990; Langin et al., 1991; Yoshida et al., 1991; Arch and Kaumann, 1993; Berlan et al., 1993) . In the mammalian heart, functional response to ␤3-AR stimulation differs among species and depends on the anatomical region within the myocardium (Gauthier et al., 2000) . For example, whereas in human and canine ventricles ␤3-AR stimulation induces negative inotropic effects (Gauthier et al., 2000) ; in human atrium, specific ␤3-AR agonists produce positive inotropic actions (Arch and Kaumann, 1993; Sennit et al., 1998) , as well as an increase of heart rate under in vivo conditions (Wheeldon et al., 1994) . However, in human atrial preparations expressing ␤3-AR subtype (Chamberlain et al., 1999) , no cardiac effects could be detected (Kaumann et al., 1997) . The ␤3-AR-induced intracellular signal pathways, which operate in cardiac tissues, have not been completely clarified. However, the negative inotropic effect has been attributed to an action mechanism that involves G i/0 proteins and results from the production of nitric oxide (NO) by the endothelial isoform of NO synthase (eNOS) with the consequent increase in intracellular cGMP levels (Gauthier et al., 1998; Varghese et al., 2000) .
Despite their importance in the vertebrate stress response, knowledge of ␤-ARs in fish is based on relatively few studies centred on a limited number of species, in which the classic cardiac adrenergic response has been mainly attributed to ␤2-AR stimulation (Gamperl et al., 1994) . In this context, the presence and role of ␤3-ARs have, until now, received surprisingly little, or no, attention.
The expression of two previously unreported ␤-ARs in the teleost Oncorhynchus mykiss was recently shown (Nickerson et al., 2003) . These two trout ␤-ARs were found to be homologous to the mammalian ␤3-AR and highly expressed in both gills and heart. However, no physio-pharmacological characterization of ␤3-ARs in fish heart or its subsequent coupling to second messengers has been reported.
The aim of this study was to analyse in the European eel Anguilla anguilla heart the physiological role of ␤3-AR and the downstream signal transduction mechanism. As in previous studies (Imbrogno et al., 2001; Imbrogno et al., 2003; Imbrogno et al., 2004) , we used juvenile eel hearts with a compact outer ventricular layer and a poorly developed coronary circulation, which allowed us to analyse the effect of cardioactive substances without interferences from the coronary vasculature. We previously reported that in the eel heart the endogenous NO signalling cascade, through a cGMP-mediated mechanism, transduces the negative inotropic effects triggered by chemical stimuli such as acetylcholine (Imbrogno et al., 2001) , angiotensin II (Imbrogno et al., 2003) and vasostatin I . We now demonstrate that ␤3-AR stimulation decreases cardiac mechanical performance through a PTxsensitive G i protein mechanism that involves a NO-cGMPcGMP-activated protein kinase (PKG) cascade.
Materials and methods

Isolated and perfused working heart preparations
We used freshwater specimens of European eel Anguilla anguilla L., weighing 85.5±2.7·g (mean ± s.e.m., N=66). Fish were provided by a local hatchery and kept at room temperature (18-20°C) without feeding for 5-7·days. In accordance with accepted standards of animal care, the experiments were organized to minimize stress and number of animals used. Experiments were performed from September to April. Each eel was anaesthetised in benzocaine (0.2·g·l -1 ) for about 15·min. The hearts, isolated and connected to a perfusion apparatus, as previously described (Imbrogno et al., 2001) , received Ringer's solution from an input reservoir and pumped against an afterload pressure given by the height of an output reservoir. The composition of the perfusate (in ·mmol·l (Imbrogno et al., 2001) . The Ringer's solution was equilibrated with a mixture of O 2 :CO 2 at 99.5:0.5%. Experiments were carried out at room temperature (18-20°C). The controlled non-paced hearts operated at a frequency of about 50·beats·min -1 (see Imbrogno et al., 2001 ). Hearts were stimulated with an LE 12006 stimulator (frequency identical to that of control, non-paced hearts; pulse width fixed at 0.1·ms; voltage: 1.2±0.1·V; means ± s.e.m.).
Measurements and calculations
Pressure was measured through T-tubes placed immediately before the input cannula and after the output cannula, and connected to two MP-20D pressure transducers (Micron Instruments, Simi Valley, CA, USA) in conjunction with a Unirecord 7050 (Ugo Basile, Comerio, Italy). Pressure measurements (input and output) were expressed in kilopascals (kPa) and corrected for cannula resistance. Heart rate (f H ) was calculated from pressure recording curves. Cardiac output (Q) was collected over 1·min and weighed; values were corrected for fluid density and expressed as volume measurements. The afterload (mean aortic pressure) was calculated as two-thirds diastolic pressure plus one-third maximum pressure. Stroke volume (V S ; ml·kg
) was used as a measure of ventricular performance; changes in V S were considered to be inotropic effects. Q and V S were normalised per kilogram of wet body mass. Ventricular stroke work [W S ; mJ·g -1 ; (afterload-preload) ϫ V S /ventricle mass] served as an index of systolic functionality.
Experimental protocols Basal conditions
Isolated perfused hearts were allowed to maintain a spontaneous rhythm for up to 15-20·min. In all experiments the control conditions were established at a mean output pressure of about 3·kPa, with a Q set to 10·ml·min -1 ·kg -1 body mass by appropriately adjusting the filling pressure. These values are within the physiological range [for references see Imbrogno et al. (Imbrogno et al., 2001) ]. Cardiac parameters were simultaneously measured during experiments. To analyse the inotropic effects distinct from the chronotropic actions of substances, the preparations were electrically paced. Hearts that did not stabilise within 20·min from the onset of perfusion were discarded.
Drug application
After the 15-20·min of control period, paced hearts were perfused for 20·min with Ringer's solution enriched with BRL 37344 at increasing concentrations (from 0.1 to 100·nmol·l -1 ) to construct cumulative concentration-response curves. Heart preparations were used to test the effects of 10·nmol·l -1 of BRL 37344 in the presence of ␤1-, ␤2-ARs antagonist nadolol, the specific ␤3-AR inhibitor SR 59230 , the nitric oxide . In another set of experiments the effects of isoproterenol (ISO), a non-specific ␤ agonist, were tested before and after treatment with a ␤ 3 -ARspecific antagonist, SR 59230 . In the above-mentioned protocols the hearts were perfused for 20·min with Ringer's solution enriched with the specific drug before the addition of BRL 37344 or ISO.
The effects of BRL 37344 (10·nmol·l -1 ) were also studied after inhibition of G-proteins by pertussis toxin (PTx); in this case the hearts were pre-incubated for 60·min with PTx.
Since the performance of the in vitro eel heart is stable for about 2h (see Imbrogno et al., 2001) , our experiments were carried out within this period.
Statistics
Percentage changes were evaluated as means ± s.e.m. of percentage changes obtained from individual experiments. Because each heart acted as its own control, a one-way ANOVA test was used for comparisons within groups (P<0.05). Comparisons between groups were made using a two-way ANOVA, Duncan's multiple-range test (P<0.05).
The concentration-response curves of the reduction of W S induced by BRL 37344 alone and by BRL 37344 plus SR 59230 were fitted using GraphPad Prism 4.02. This provided the -log of the concentration (in mol·l -1 ) that induced the 50% effect (EC 50 ) of BRL 37344 alone and BRL 37344 plus SR 59230 . 3-a] quinoxalin-1-one (ODQ) and pertussis toxin (PTx) were purchased from Sigma Chemical Company (St Louis, MO, USA). KT 5823 (used in a darkened perfusion apparatus to prevent degradation) was purchased from Calbiochem (Milan, Italy). All the solutions were S. Imbrogno and others prepared in double-distilled water (ODQ and KT 5823 were prepared in DMSO); dilutions were made in Ringer's solution immediately before use.
Drugs and chemicals
[4-[2-[[2-(3-chlorophenyl)-2-hydroxy-ethyl]amino]propyl]- phenoxy]acetic acid sodium (BRL 37344 ), 3-(2-ethylphenoxy)- 1-[[(1S)-1,2,3,4-tetrahydronaphth-1-yl]amino]-(2S)-2-propanol oxalate salt (SR 59230 ), isoproterenol (ISO), nadolol, haemoglobin (Hb), L-N 5 -(1-iminoethyl)ornitine (L-NIO), 1H-[1,2,4]oxadiazole-[4,
Results
Isolated heart preparation
After equilibration, the in vitro isolated and perfused heart preparation works at physiological loads and generates values of output pressure, f H , Q, V S and W S that mimic the physiological values of the in vivo animal [see Imbrogno et al. (Imbrogno et al., 2001) for references].
Baseline variables for the resting heart preparations were: output pressure (kPa) = 2.63±0.53; f H (beats·min Effects of ␤ 3 -adrenergic stimulation on basal cardiac performance Concentration-response curves of selective ␤3-AR agonist were generated by exposing the cardiac preparations to increasing concentrations of BRL 37344, since exposure to single repeated doses of BRL 37344 revealed absence of receptor desensitization (data not shown). The effects of the agonist remained stable for 15·min then gradually decreased with time. Accordingly, cardiac parameters were measured after 10·min. BRL 37344 (0.1-100·nmol·l -1 ) induced a concentrationdependent negative inotropic effect, revealed by a significant reduction of both V S , starting from the concentration of 1·nmol·l -1 , and W S , above 10·nmol·l -1 (Fig.·1) . 
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Effects of BRL 37344 after treatment with nadolol To explore putative interactions between ␤ 1 /␤ 2 -and ␤ 3 -adrenergic signalling, hearts were perfused with the ␤ 3 -AR agonist BRL 37344 (10·nmol·l -1 ) in presence of a specific ␤ 1 /␤ 2 -ARs inhibitor, nadolol (10·mol·l -1 ). Two-way ANOVA test showed no significant differences between the untreated (with antagonist) and antagonist-treated preparations suggesting that the negative inotropic effect induced by BRL 37344 is not influenced by ␤ 1 /␤ 2 -AR inhibition (Fig.·2) . (Fig.·3) indicate a competitive antagonism of SR 59230 on the ␤ 3 -AR-mediated negative inotropism.
Effects of BRL
Effects of ISO after treatment with SR 59230
Isoproterenol (ISO), a non-specific ␤-AR agonist, generally produces positive inotropic and chronotropic effects in the heart (Brodde, 1991) . In our study, in addition to the classic positive inotropism (data not shown), ISO (100·nmol·l -1 ) stimulation, in 30% of preparations, induced a negative inotropic effect that was abolished by pre-treatment with SR 59230 (Fig.·4) .
G protein interaction
␤3-AR belongs to the guanine nucleotide-binding protein (G protein)-coupled receptor super family characterized by seven transmembrane segments (Skeberdis, 2004) . To verify the involvement of G proteins in the ␤3-AR-induced inotropic action, cardiac preparations were perfused with Ringer's solution containing PTx (0.01·nmol·l -1 ) in presence of BRL 37344 . In the rat heart, PTx catalyzes the ADP-ribosylation of the alpha-subunit of G i/o and uncouples the interaction between G i and several inhibitory receptors, including muscarinic receptors [Angelone et al. (Angelone et al., 2006) and references therein]. Whereas PTx alone did not modify basal cardiac performance (data not shown), its pre-treatment abolished the BRL 37344 -dependent negative inotropic effect (i.e. V S and W S ; Fig.·5 
Involvement of NO-cGMP-PKG signal transduction pathway
NO, via activation of GC, is an important modulator of cardiac performance in the in vitro working eel heart (Imbrogno et al., 2001; Imbrogno et al., 2003; Imbrogno et al., 2004) .
The involvement of the NO-cGMP-PKG signalling in the BRL 37344 -dependent inotropism, was examined by perfusing cardiac preparations with either Hb (1·mol·l -1 ), or L-NIO (10·mol·l -1 ), or ODQ (10·mol·l -1 ). All these treatments abolished the effect of the ␤3-AR agonist demonstrating its dependence on a NO-cGMP mechanism (Fig.·6) . Since cGMP modulates cardiac contractility via activation of a cGMP-PKG pathway (Hove-Madsen et al., 1996) , and this is known to be the case also in the eel heart (Imbrogno et al., 2003) , we pretreated the heart with a specific PKG inhibitor (KT 5823 , ). This abrogates the BRL 37344 -dependent reduction of V S and W S (Fig.·6) , indicating the involvement of PKG in the ␤ 3 -AR-induced inotropic response.
Discussion
This study provides physio-pharmacological evidence for the existence of functional ␤3-like adrenoceptors in the heart of A. anguilla. On the isolated working eel heart, we show that activation of ␤3-AR induces a clear negative inotropic action. This negative inotropism is coupled with PTx-sensitive inhibitory G i proteins and involves an NO-cGMP-PKG signal transduction pathway.
Effects of ␤3-AR stimulation
In the eel, ␤3-AR stimulation negatively affects cardiac performance. This conclusion is based on several lines of evidences. Treatment with BRL 37344 , a preferential ␤3-AR agonist (Arch and Wilson, 1996; Balligand, 2000) , induces a S. Imbrogno and others dose-dependent negative inotropic effect. As revealed by the analysis of the percentage of W S variations in terms of EC 50 values, this negative inotropism was blocked by the ␤3-AR specific antagonist SR 59230 , which in the eel heart acts in a competitive manner. Inversely, it was not modified by nadolol, a ␤1-and ␤2-ARs inhibitor, free of ␤3-AR antagonist properties (Emorine et al., 1989; Galitzky et al., 1993) , ruling out the involvement of ␤1-and ␤2-ARs. Moreover, according to the results obtained in dog (Pelat et al., 2003) and in human ventricular biopsy (Gauthier et al., 1996) , in the eel heart, in addition to the classic ISO-dependent positive inotropic effect , non-specific ␤-AR stimulation induced, in about 30% of preparations, a negative inotropism which was abrogated by SR 59230 pre-treatment. No data are currently available regarding the factors that can influence the sensitivity of the eel heart to isoproterenol stimulation (i.e. specific agonist concentration, seasonal factors, etc). However, our observations further support the pharmacological evidence of the ␤3-AR functional expression in the eel heart.
In mammals, the cardiac response to ␤3-AR stimulation depends not only by species-related differences, but also by the organizational level under study (i.e. in vivo cardiovascular system vs isolated and denervated working heart) and the functional interactions among its components [Gauthier et al., (Gauthier et al., 1996) and references therein]. For example, beyond the negative inotropism observed in human (Gauthier et al., 1996) , dog and guinea pig (Kitamura et al., 2000) references]. However, these in vivo effects were not related to a direct stimulation of cardiac ␤3-AR but to reflex mechanisms (Tavernier et al., 1992; Wheeldon et al., 1993; Wheeldon et al., 1994; Shen et al., 1996) . Thus, the eel heart preparation used in this study being free of extrinsic nervous and humoral influences, it is a very appropriate model to analyse the cardiac effects of ␤3-AR. Our data clearly indicate that, as reported in human (Gauthier et al., 1996) , dog and guinea pig (Kitamura et al., 2000) , also in the eel ␤3-AR stimulation depresses cardiac contraction. This effect has been observed beginning from a BRL 37344 concentration of 0.1·nmol·l
, obtaining a reduction of 27±3.6% for V S and of 27.9±3% for W S at the higher concentration tested (100·nmol·l -1 ). Notably, these concentrations are similar to those observed in mammals, in which the maximum effect was obtained by BRL 37344 (1·mol·l -1 ) in human myocardium, CL 316243 (1·mol·l -1 ) in guinea-pig, CGP 12177 (0.1·mol·l -1 ) in dog and BRL 37344 (0.1·mol·l -1 ) in rat . Moreover, in light of the classification proposed by Gauthier et al. for mammalian hearts as hyperresponders (human and dog), hypo-responders (rat and guinea pig) and non-responders (ferret) to ␤3-AR agonists stimulation, the elevated sensitivity of the eel heart to BRL 37344 , shown by V S reduction of about 30%, allows it to be classified within the hyper-responder group. In mammals, the interspecies variability and the heterogeneous pharmacological profile of ␤3-AR agonists were correlated to cardiac ␤3-AR expression. For example, it has been reported that the negative inotropic effect induced by ␤3-AR agonists in human and dog is associated with the presence of ␤3-AR transcripts . By contrast, no ␤3-AR mRNA was detected in the hypo-responder rat ventricular myocardium and rat right ventricle (Evans et al., 1996) . Interestingly, Nickerson et al. (Nickerson et al., 2003) have recently cloned and characterized in the rainbow trout, Oncorhynchus mykiss, two previously unreported ␤-ARs (i.e. ␤3a-AR and ␤3b-AR), homologous to the mammalian ␤3-AR. Analysis of tissue expression patterns indicated elevated levels of ␤3a-AR mRNA in both gills and heart and lower levels in red muscle (Nickerson et al., 2003) . However, the receptor expression level may not be the unique factor governing the cardiac response to ␤3-AR stimulation. In fact, important interspecies differences in the amino acid sequences of ␤3-ARs have been reported in mammals (Strosberg and Pietri-Rouxel, 1996; Gros et al., 1998) . These differences concern transmembrane regions that are considered crucial for ligand binding and G protein interaction (Strosberg and Pietri-Rouxel, 1996) . The presence of ␤3-AR transcripts in the heart of O. mykiss, together with the high functional sensitivity to BRL 37344, that we have documented in A. anguilla, emphasize the importance of a putative cardiac ␤3-AR control in teleosts.
Transduction mechanism G-proteins interaction
The mechanisms by which ␤3-AR activation induces cardiodepressing effects are largely unknown. We show here that in the eel heart, the negative inotropism induced by BRL 37344 , is abolished by the pre-treatment with PTx, the toxin which uncouples signal transduction between several families of receptors and G i/o proteins [Ai et al. (Ai et al., 1998) and references therein]. Accordingly, there is indication that the ␤3-AR-dependent negative inotropy involves PTx-sensitive G proteins. Our data agree with those obtained in human ventricular biopsies, in which PTx abolished the effect of ␤3-AR stimulation on cardiac contraction (Gauthier et al., 1996; Gauthier et al., 1998) . In the heart, PTx-sensitive G proteins, located at the interface between receptor-response coupling, are involved in various inhibitory transduction cascades triggered by both chemical and physical stimuli (Hare et al., 1998) . In the rat heart, ␤3-ARs, acting through a G i protein, mediate the inhibitory effect of BRL on L-type Ca 2+ current (Zhang et al., 2005) . Moreover, in human heart the PTx-sensitive-␤3-ARinduced negative inotropic effect was associated with decreased action potential amplitude and reduced action potential duration (Gauthier et al., 1996) . Whether in the eel heart the BRL-induced cardio-suppressive effect involves these or other mechanisms remains to be elucidated.
NO-cGMP-PKG signal transduction pathway
In human ventricle, the ␤3-AR-induced negative inotropic action results from the production of NO by the endothelial isoform of NO synthase (eNOS) and the consequent increase in intracellular cGMP (Gauthier et al., 1998; Varghese et al., 2000) . The role of NO in mediating inotropic effects induced by cardioactive agents has been extensively demonstrated in the eel by our lab. For example, direct stimulation of M 2 muscarinic acetylcholine receptors (Imbrogno et al., 2001) and AT 1 angiotensin II receptors (Imbrogno et al., 2003) , or exposure to vasostatin I decreased contractility through NOS stimulation and a consequent increased cGMP production. Consistent with the expression of NOS in the eel heart (Tota et al., 2005) , we have found that the ␤3-AR-induced inotropism is mediated by the NO-cGMP-PKG pathway. This was demonstrated by its abrogation following pre-treatment with either the NO scavenger (Hb), or NOS (L-NIO), or soluble GC (ODQ), or PKG inhibitors (KT 5823 ). In the eel heart, an important intramyocardial target of NO signalling is PKG (Imbrogno et al., 2003; Imbrogno et al., 2004) . In isolated mammalian ventricular cardiomyocytes (Méry et al., 1991) , PKG affects Ca 2+ influx and, through phosphorylation of troponin I, reduces the affinity of troponin C for calcium, thereby negatively regulating cardiac contractility (HoveMadsen et al., 1996) .
In conclusion, the present study, for the first time, extends to a working fish heart the negative inotropic action induced by ␤3-AR stimulation previously reported in mammals. This effect occurs via a G i/o -NO-cGMP-PKG signal transduction pathway. The functional evidence for the presence of ␤3-AR in the heart of an ectotherm vertebrate suggests its ancient evolutionary origin and strongly supports important functions independent from thermogenic response. In view of the postulated role of ␤3-AR as a homeostatic regulator of the cardiovascular system, possibly counteracting the excitatory adrenergic influences (Sterin-Borda et al., 2006) , it is of interest that in the teleost heart, activation of ␤3-ARs induces cardiosuppressive actions. Indeed, the heart of many teleosts, including the eel, are exposed to stimulatory effects of circulating and intracardiac catecholamines, particularly under stress conditions [Imbrogno et al. (Imbrogno et al., 2003) for references], which may became harmful in the absence of local counter-regulatory mechanisms. The possibility that in fish ␤3-AR could exert cardio-inhibitory protection versus systemic and/or intracardiac cascades of excitatory stimuli targeting the heart is a challenge for future studies. We are grateful to Laura Jean Carbonaro for editing the text. The study was supported in part by a grant from Dottorato di Ricerca in Biologia Animale (C.A. and E.P.).
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